The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

ClinicalTrials.gov ID: NCT06315023

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06315023. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Single Arm, Registry-based Study to Evaluate the Real-world Use of the DETOUR™ System in US Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.

Study identification

NCT ID: NCT06315023
Recruitment status: Enrolling by invitation
Study type: Observational
Phase: Not listed
Lead sponsor: Endologix; Industry
Enrollment: 450 participants

Conditions and interventions

Conditions

Interventions

DETOUR System Device

Device

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 6, 2023 (Actual)
Primary completion: Jun 7, 2028 (Estimated)
Completion: Jun 7, 2032 (Estimated)
Last update posted: May 12, 2026

2023 – 2032

United States locations

U.S. sites: 10
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
Salinas Valley Memorial Hospital	Salinas	California	93901	—
University of Connecticut	Storrs	Connecticut	06269	—
Medstar Washington Hospital Center	Washington D.C.	District of Columbia	20010	—
Delray Medical Center	Delray Beach	Florida	33484	—
Beth Isreal Deaconess Medical Center	Boston	Massachusetts	02215	—
Saint Luke's Hospital of Kansas City	Kansas City	Missouri	64111	—
NYU Langone Medical Center	New York	New York	10016	—
Cleveland Clinic Main Campus	Cleveland	Ohio	44195	—
University of Pennsylvania	West Chester	Pennsylvania	19380	—
Main Line Health	Wynnewood	Pennsylvania	19096	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06315023, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 12, 2026 · Synced Nov 14, 2026